Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated rhG-CSF versus daily rhG-CSF for neutrophil recovery in acute myeloid leukemia
ChiCTR-TRC-14004836Phase 4Not yet recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute myeloid leukemia (AML) comparing peg-rhG-CSF with rhG-CSF (2 arms). Primary endpoint: Days of neutrophil recovery. Planned start Jun 2014; status: not yet recruiting.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on ChiCTR-TRC-14004836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004836.